Julius Clinical Strengthens its European Capabilities by Expanding Operations in Poland
ZEIST, Netherlands, Feb. 25, 2025 /PRNewswire/ -- Julius Clinical, a science-driven global CRO specializing in Neurological, Cardio-Metabolic, Renal and Rare Diseases, is pleased to announce the establishment of Julius Clinical Poland, a new operational hub in Krakow. This expansion reinforces Julius Clinical's position as a global leader in CNS and Cardio-Metabolic research while enhancing its pan-European capabilities in clinical trials.
With a strong track record of over 15 clinical trials conducted in Poland during the last years, Julius Clinical recognizes the country's exceptional potential as a key clinical research hub in Europe. Poland offers a highly skilled workforce, a robust healthcare infrastructure, and a proven commitment to clinical research, making it an optimal destination for expanding the company's European footprint. The new affiliate will enable more efficient patient recruitment, improved site selection, and seamless regulatory compliance, ultimately accelerating the development of innovative therapies.
Martijn Wallert, CEO of Julius Clinical, said: "Expanding into Poland marks a strategic milestone for Julius Clinical. We are strengthening our presence in Eastern Europe, making Poland a central hub for our regional operations and expanding our ability to support clinical research across neighboring countries."
Radek Korba, Country Manager Poland, brings long-standing collaboration experience with Julius Clinical, ensuring a smooth transition for customers and partners. "Poland is a pivotal market in clinical research, and our local presence allows us to drive innovation while maintaining the highest standards of quality and compliance. We are excited to strengthen collaborations with investigators, healthcare institutions, and regulatory bodies to deliver impactful research," said Korba.
Julius Clinical's expansion into Poland aligns with its broader strategy of providing world-class, scientifically driven clinical research services globally. With this move, the company reinforces its commitment to accelerating medical breakthroughs through cutting-edge trial designs, access to diverse patient populations, and deep scientific expertise.
Julius Clinical is supported by Ampersand Capital Partners, a leading private equity firm with deep expertise in the life sciences and healthcare sectors.
About Julius Clinical
Founded in 2008 and headquartered in Zeist, The Netherlands, Julius Clinical is a leading CRO specializing in CNS, Cardio-Metabolic, Renal, and Rare Diseases. With over 380 clinical trials and 220,000+ subjects across 39 countries, Julius Clinical combines scientific leadership, operational excellence, and a global network of research sites to deliver tailored solutions for pharmaceutical, biotechnology, and academic partners.
For more information, visit https://www.juliusclinical.com or follow us on LinkedIn.
About Ampersand Capital Partners
Ampersand Capital Partners, founded in 1988, is a middle-market private equity firm with $3 billion of assets under management, dedicated to growth-oriented investments in the healthcare sector. With offices in Boston, MA, and Amsterdam, The Netherlands, Ampersand leverages a unique blend of private equity and operating experience to build value and drive long-term performance alongside its portfolio company management teams. Ampersand has helped build numerous market-leading companies across each of the firm's core healthcare sectors.
For additional information, visit https://ampersandcapital.com or follow us on LinkedIn.
For more information on Julius Clinical services:
Email: businessdevelopment@juliusclinical.com
For more information on this press release, please contact:
Toni KovandjievaMarketing Manager, Julius ClinicalEmail: toni.kovandjieva@juliusclinical.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/julius-clinical-strengthens-its-european-capabilities-by-expanding-operations-in-poland-302383994.html
SOURCE Julius Clinical Research
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Construction of mixed-use development Sensorium completes in France
Eiffage Construction, a division of European construction company Eiffage, has announced the completion of the Sensorium, a mixed-use development in France. Located at the entrance of La Madeleine, near Vieux-Lille, the Sensorium is a project delivered by Eiffage Construction, which served as the general contractor. The development, which took nearly three years to complete, features 135 housing units, including 41 social rental units and adapted housing for young adults with autism-spectrum disorders, alongside 18,000m² of office space, shops, restaurants, collaborative spaces, and outdoor areas. The entire development is centred around a new city gateway square, which includes a central park filled with trees, a public square, a pedestrian walkway, children's play areas, and a two-way access road. This project has also seen the planting of more than 300 trees, quadrupling the initial number. The rooftops of the Sensorium boast shared terraces that are accessible to all residents, complete with vegetable gardens, fruit trees, and climbing plants, contributing to the greenery of the development. The project prioritised environmental sustainability, with the use of low-carbon concrete throughout the construction. The office space foundation slab's concrete saved an estimated 280 tonnes of carbon dioxide emissions, Eiffage stated. In terms of energy performance, the development's office spaces are aiming for Building Research Establishment Environmental Assessment Method Excellent certification and the Haute Qualité Environnementale Sustainable Building and E2C1 labels while the housing units are targeting the BEE+ label. The construction site engaged up to 200 workers and utilised four cranes, with logistics managed to allow the simultaneous construction of the office and housing phases. The project team includes Bouygues Immobilier and Sogeprom-Projectim as project owners, Dehaene + partenaires architectes urbanistes as the architect, and several engineering and construction economy companies such as PROJEX, DIAGOBAT, EGIS, URBA FOLIA, and OPTIBAT. Eiffage Énergie Systèmes handled the electrical, heating, ventilation, and air conditioning, and building management systems for the offices while Eiffage Route was responsible for roadworks and utilities. Earlier this April, Eiffage Construction also completed the delivery of three production halls for Airbus Atlantic in Rochefort, France. "Construction of mixed-use development Sensorium completes in France" was originally created and published by World Construction Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
20 minutes ago
- Yahoo
Tesla stock rises as Trump-Musk feud cools and robotaxi launch nears
Tesla stock rose marginally in pre-market trading on Wednesday after CEO Elon Musk extended an olive branch to US President Donald Trump following their public feud. Shares were up over 2% by around midday CEST, at $332.76 (€290.98) 'I regret some of my posts about President @realDonaldTrump last week. They went too far,' Musk said in a post on X on Wednesday. After spending millions backing Trump's successful presidential bid, Musk heavily criticised the Republicans' new tax and spending bill, creating a rift between the two men. Musk was previously appointed by Trump to lead DOGE, the US' Department of Government Efficiency. The tech billionaire argued that the new bill, dubbed by Trump as the 'One Big Beautiful Bill Act', would irresponsibly raise the public deficit and undermine DOGE's work. Musk resigned from the department in late May after saying he was 'disappointed' with spending proposals. In an escalation of the conflict last week, Musk called for Trump to be impeached and replaced with Vice President JD Vance. He also implied that Trump was linked with late sex offender Jeffrey Epstein, an allegation the White House denied. Related The 100 ways Elon Musk and his companies allegedly benefited from working with Donald Trump Tesla's European buyers turn away? Sales slide amid Musk's political controversy As for the president, Trump threatened to terminate government contracts awarded to Musk's SpaceX firm. On Monday, the president then took a more conciliatory tone. Trump said he wished Musk 'very well' and claimed that he would retain Starlink internet service at the White House. Even so, the US President suggested that he might remove his own Tesla from White House grounds. The value of Tesla shares have been rocked by volatility as investors track the dramas playing out in Washington — and some dump stock in protest of Musk's politics. Both Argus Research and Baird downgraded ratings for Tesla stock on Monday, which has seen its value drop by more than 19% since the start of the year. Aside from the Trump-Musk feud, experts noted that risks to Tesla include the expiration of EV credits, which could dampen demand. A $7,500 tax credit for an EV purchase is set to be fully eliminated by the end of 2026, although restrictions will be applied before this. For those wishing to use the credit in 2026, they can only buy from manufacturers that haven't yet sold 200,000 EVs. This would disqualify Tesla. Other challenges include increased competition in the EV market, particularly from Chinese rivals such as BYD. Despite these storm clouds ahead, Musk's enthusiasm about robotaxis appears to be inflating the stock's value. The CEO is currently hoping to roll out the self-driving taxi service in Austin, Texas, on 22 June. In a post on his X social media platform, Musk said the date could change because Tesla is 'being super paranoid about safety'. Sign in to access your portfolio
Yahoo
22 minutes ago
- Yahoo
NATO summit statement omits Ukraine's entry bid, $40 billion pledge, Bloomberg reports
A one-page draft of a joint declaration for the upcoming NATO summit omits Ukraine's membership aspirations and last year's pledge of over $40 billion in support, Bloomberg reported on June 11 after reviewing the draft. This news signals that, for the first time since 2022, Russia's war against Ukraine will not be the chief focus of the annual NATO meeting, which is taking place on June 24-25 in The Hague. The unusually brief document recognizes Russia as a threat to NATO but not as an aggressor in Ukraine. It also does not mention China, Bloomberg reported. The communique of the 2024 summit in Washington named Beijing as a "decisive enabler" of Russia's war against Ukraine. Last year's gathering also included a declaration that Ukraine's path to NATO is "irreversible" and promised more than $40 billion in additional military aid. This year, the document will solely focus on defense spending, as U.S. President Donald Trump pushes NATO partners to hike the military expenditure benchmark from 2% to 5% of GDP. The final version of the statement can still change, Bloomberg reported. The brevity of the communique and the summit itself, as well as the decreased focus on Ukraine, stems from the effort to avoid conflict between Trump and European allies. In a sharp break from former U.S. President Joe Biden, the Trump administration has not approved any new military aid packages to Ukraine and signaled its intent to reduce assistance for Kyiv in the next year's budget. The U.S. president initially vowed to broker a peace deal between Kyiv and Moscow but became increasingly less engaged in the process as the negotiations stalled and Russia only intensified its attacks against Ukraine. According to Bloomberg, NATO allies will pledge to allocate at least 3.5% of GDP to defense needs and 1.5% to protecting infrastructure and civil preparedness by 2032. Member states will also consider counting their contributions to Ukraine as part of the new defense spending targets, the news outlet reported. The summit was preceded by rumors that President Volodymyr Zelensky would not be invited to participate for the first time due to U.S. opposition. Later, the speculations were dispelled after the Dutch media reported that NATO Secretary General Mark Rutte had invited the Ukrainian leader to attend. Read also: As Russia inches closer to Dnipropetrovsk Oblast, new Ukrainian region might soon be at war We've been working hard to bring you independent, locally-sourced news from Ukraine. Consider supporting the Kyiv Independent.
